Our Experts
Contributors & Intelligence Network
Helixgate Biotech Review brings together leading voices across biotechnology, advanced research, computational sciences, and capital markets.
Our contributors include scientists, founders, investors, and strategic operators shaping the future of life sciences.
Dr. Elena Vasquez
Senior Intelligence Analyst
AI & Drug Discovery
Prof. James Chen
Contributing Editor
Synthetic Biology
Prof. Chen is a leading researcher in metabolic engineering and synthetic biology at MIT. His work focuses on engineering microbial systems for industrial biotechnology.
Dr. Sarah Okafor
Contributing Analyst
Gene Therapy & Cell Therapy
Dr. Okafor specializes in gene therapy vector development and has contributed to multiple clinical-stage gene therapy programs at leading biotech companies.
Dr. Michael Torres
Contributing Analyst
Diagnostics & Precision Medicine
Dr. Priya Sharma
Contributing Editor
Regulatory & Policy
Dr. Sharma specializes in biotechnology regulatory affairs and science policy, with experience at the FDA and major regulatory consulting firms.
Mason Strathmore
Join Us
Call for Contributors
Mason Strathmore
Helixgate Biotech Review | Shadowgate Visionary Innovations
Mason Strathmore is the Founder of Helixgate Biotech Review and a strategic operator at the intersection of biotechnology, advanced computational systems, and capital infrastructure.
His work focuses on bridging scientific innovation with scalable capital deployment, with an emphasis on accelerating drug discovery timelines, research efficiency, and infrastructure development across the life sciences sector.
Through Helixgate, Mason is building a high-tech intelligence platform designed to connect leading biotech organizations, research institutions, and investment groups with next-generation operating systems and strategic insights.
Founding Contributors (Invited Network)
Senior Scientist — Immunotherapy & Oncology
Director of Drug Discovery — Top 10 Pharma
AI/ML Research Lead — Computational Biology
Venture Partner — Life Sciences Investment Fund
Clinical Research Strategist — Phase II/III Trials
Biotech Infrastructure Developer — Lab & Campus
Contributor Domains
Our intelligence network is categorized into four critical pillars of the life sciences ecosystem.
Scientific Contributors
Researchers, PhDs, and lab directors driving the next wave of biotech innovation.
Focus: Discoveries, Methodologies
Computational & Systems
AI, ML, and Data Modeling experts building the digital infrastructure.
Focus: Acceleration, Simulation
Capital & Investment
PE, VC, and Family Offices funding the future of scalable biotechnology.
Focus: Deal Flow, Scaling
Infrastructure & Dev
Specialists in life science real estate and advanced lab build-outs.
Focus: Physical Ecosystems
Join the Helixgate Intelligence Network
- Editorial Integrity & Standards
All contributions are reviewed for scientific accuracy, strategic relevance, and industry impact. Helixgate Biotech Review maintains a high standard of clarity, credibility, and forward-thinking analysis across all published materials.